CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2025	Mar. 31, 2024
Revenue
Total revenue, net	$ 2,214	$ 2,351
Operating expenses
Cost of product revenue	515	430
Research and development	3,730	4,312
Sales and marketing	2,493	1,443
General and administrative	4,897	4,381
Total operating expenses	11,635	10,566
Loss from operations	(9,421)	(8,215)
Other income	112	234
Interest income (expense)	56	(611)
Changes in fair value of freestanding and hybrid financial instruments designated at Fair Value Option	(1,343)	(2,021)
Gain on extinguishment of debt		1,245
Loss before income tax expense	(10,596)	(9,368)
Net loss before equity in net loss of Joint venture	(10,596)	(9,368)
Net loss	(10,596)	(9,368)
Net loss attributable to noncontrolling interest	(132)	(142)
Net loss attributable to common stockholders	$ (10,464)	$ (9,226)
Net loss per share, basic	$ (16.7)	$ (87.12)
Net loss per share, diluted	$ (16.7)	$ (87.12)
Weighted-average common stock outstanding, basic	626,644	105,895
Weighted-average common stock outstanding, diluted	626,644	105,895
Product revenue, net
Revenue
Total revenue, net	$ 2,171	$ 2,351
License revenue
Revenue
Total revenue, net	$ 43